Evidence map›Paper›PMID 35317082›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Virtual reality cognitive intervention for heart failure: CORE study protocol.

Miyeon Jung, Liana G Apostolova, Debra K Moser, Irmina Gradus-Pizlo, Sujuan Gao, Jeff L Rogers, Susan J Pressler

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Miyeon JungIndiana University School of Nursing Indianapolis Indiana USA.
Liana G ApostolovaIndiana University School of Medicine, Department of Neurology, Radiology, and Medical and Molecular Genetics Indianapolis Indiana USA.
Debra K MoserUniversity of Kentucky College of Nursing Lexington Kentucky USA.
Irmina Gradus-PizloDepartment of Medicine University of California Irvine School of Medicine Orange California USA.
Sujuan GaoDepartment of Biostatistics and Health Data Science Indiana University School of Medicine Indianapolis Indiana USA.
Jeff L RogersIndiana University UITS Advanced Visualization Lab Indianapolis Indiana USA.
Susan J PresslerIndiana University School of Nursing Indianapolis Indiana USA.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineUniversity of California, Irvine · USUniversity of Kentucky · US

Funding

Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI SUJUAN GAO · 2021 to 2026
$24.1M
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart FailureK76AG074940 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI Miyeon Jung · 2022 to 2026
$1.2M
NIA NIH HHS P30 AG072976
6 · The paper itself

Abstract

Introduction: Heart failure (HF) is a prevalent, serious chronic illness that affects 6.5 million adults in the United States. Among patients with HF, the prevalence of attention impairment is reported to range from 15% to 27%. Although attention is fundamental to human activities including HF self-care, cognitive interventions for patients with HF that target improvement in attention are scarce. The COgnitive intervention to Restore attention using nature Environment (CORE) study aims to test the preliminary efficacy of the newly developed Nature-VR, a virtual reality-based cognitive intervention that is based on the restorative effects of nature. Nature-VR development was guided by Attention Restoration Theory. The target outcomes are attention, HF self-care, and health-related quality of life (HRQoL). Our exploratory aims examine the associations between attention and several putative/established HF biomarkers (eg, oxygen saturation, brain-derived neurotrophic factor, apolipoprotein E, dopamine receptor, and dopamine transporter genes) as well as the effect of Nature-VR on cognitive performance in other domains (ie, global cognition, memory, visuospatial, executive function, and language), cardiac and neurological events, and mortality. Methods: This single-blinded, two-group randomized-controlled pilot study will enroll 74 participants with HF. The Nature-VR intervention group will view three-dimensional nature pictures using a virtual reality headset for 10 minutes per day, 5 days per week for 4 weeks (a total of 200 minutes). The active comparison group, Urban-VR, will view three-dimensional urban pictures using a virtual reality headset to match the Nature-VR intervention in intervention dose and delivery mode, but not in content. After baseline interviews, four follow-up interviews will be conducted to assess sustained effects of Nature-VR at 4, 8, 26, and 52 weeks. Discussion: The importance and novelty of this study consists of using a first-of-its kind, immersive virtual reality technology to target attention and in investigating the health outcomes of the Nature-VR cognitive intervention among patients with HF.

Indexed as

apolipoprotein Eattentionaugmented realitybiomarkersbrain‐derived neurotrophic factorclinical trial protocolcognitiondopamine receptordopamine transportergenomicsheart failurevirtual reality

Identifiers

PMID35317082
PMCPMC8923344
OpenAlexW4220797359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.